July 6, 2021
FDA: Class I recall of Medtronic angiographic guidewire
Editor's Note
The Food and Drug Administration (FDA) on July 2 identified the recall by Medtronic Vascular of its angiographic guidewire component as Class I, the most serious.
The recall was initiated because the devices were not sterilized before being shipped to hospitals.
The guidewire is used during angiography or other interventional procedures to help place catheters into the vasculature.
There have been 2 complaints and no reported injuries or deaths. Distribution dates were November 23, 2007, to March 29, 2021.
Free Daily News
- Call for improved suicide risk screening in ASCs aims to strengthen safety protocols
- Study: Perioperative pregabalin reduces risk of kidney decline compared to gabapentin
- Medical school diversity declines after Supreme Court ruling
- Surgeons risk losing ground as transcatheter tricuspid valve interventions rise
- Bain Capital seeks full acquisition of Surgery Partners amid growing private equity interest in healthcare
- Study: Sleep surgery reduces motor vehicle accident risk in OSA patients
- Health systems embrace multi-year medical technology partnerships
- Health system leader survey respondents brace for 2025 shifts
- Initiative addresses nurses' underrepresentation in health media
- Pig organ transplant recipient remains healthy, sets xenotransplant record
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement